OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Showing 17 citing articles:
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 36
Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 8
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 8
Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies
Szilvia Lukácsi, Gyöngyi Munkácsy, Balázs Győrffy
Integrative Cancer Therapies (2024) Vol. 23
Open Access | Times Cited: 6
Szilvia Lukácsi, Gyöngyi Munkácsy, Balázs Győrffy
Integrative Cancer Therapies (2024) Vol. 23
Open Access | Times Cited: 6
A protracted war against cancer drug resistance
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review
Nan Yao, Wenqiang Li, Ning Duan, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e36957-e36957
Open Access | Times Cited: 5
Nan Yao, Wenqiang Li, Ning Duan, et al.
Medicine (2024) Vol. 103, Iss. 2, pp. e36957-e36957
Open Access | Times Cited: 5
Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance
Daosong Dong, Yu Xue, Jingjing Xu, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101125-101125
Closed Access | Times Cited: 5
Daosong Dong, Yu Xue, Jingjing Xu, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101125-101125
Closed Access | Times Cited: 5
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies
Arunabh Arandhara, Pallabi Bhuyan, Bhrigu Kumar Das
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Arunabh Arandhara, Pallabi Bhuyan, Bhrigu Kumar Das
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Long-term chronic exposure to benzo[a]pyrene and catechol induced multidrug resistance in lung cancer cells
Tongkuo Yuan, Yu Zheng, Jing Chen, et al.
Environmental Pollution (2025) Vol. 369, pp. 125859-125859
Closed Access
Tongkuo Yuan, Yu Zheng, Jing Chen, et al.
Environmental Pollution (2025) Vol. 369, pp. 125859-125859
Closed Access
Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression
Achilleas Mitrakas, Christos Kakouratos, Ioannis Lamprou, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 853-853
Open Access
Achilleas Mitrakas, Christos Kakouratos, Ioannis Lamprou, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 853-853
Open Access
Spatial oncology: Translating contextual biology to the clinic
Dennis Gong, Jeanna M Arbesfeld-Qiu, Ella Perrault, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 4
Dennis Gong, Jeanna M Arbesfeld-Qiu, Ella Perrault, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 4
Shifting the paradigm: engaging multicellular networks for cancer therapy
Joyce Hu, Paolo A. Ascierto, Alessandra Cesano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Joyce Hu, Paolo A. Ascierto, Alessandra Cesano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
Ziyang Steve Yin, Zhengfeng Wang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ziyang Steve Yin, Zhengfeng Wang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Future Perspectives of Cancer Immunotherapy for the Treatment of Lung Cancer
Dhruv Gupta, Saritha Shetty
(2024), pp. 373-389
Closed Access
Dhruv Gupta, Saritha Shetty
(2024), pp. 373-389
Closed Access
Nanomedicine-Based Cancer Immunotherapy
Syed Hammad Ali, Mohammad Azhar Aziz
Interdisciplinary cancer research (2024)
Closed Access
Syed Hammad Ali, Mohammad Azhar Aziz
Interdisciplinary cancer research (2024)
Closed Access
Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access
Yuening Dai, Xi Tian, Xuanting Ye, et al.
Cancer Drug Resistance (2024)
Open Access
Application of nanomaterials in precision treatment of lung cancer
Chengcheng Zhang, Jiang Fan, Liang Wu
iScience (2024) Vol. 28, Iss. 1, pp. 111704-111704
Open Access
Chengcheng Zhang, Jiang Fan, Liang Wu
iScience (2024) Vol. 28, Iss. 1, pp. 111704-111704
Open Access
Choroid plexus tumors: A spectrum from benign to malignant
Ali A. Mohamed, Thomas Caussat, Sophie Kelly, et al.
Tumor Discovery (2023) Vol. 2, Iss. 2, pp. 1057-1057
Open Access | Times Cited: 1
Ali A. Mohamed, Thomas Caussat, Sophie Kelly, et al.
Tumor Discovery (2023) Vol. 2, Iss. 2, pp. 1057-1057
Open Access | Times Cited: 1
